LAURUS LABS | CLARIFICATION
Co. Days The ARV medicine market is ~US$ 1.5bn, representing 10% of the annual HIV budget, funded by governments, PEPFAR, and the Global Fund. Global efforts have effectively controlled AIDS. Despite potential funding challenges, the Company believes medication procurement won’t be impacted.
The U.S. rejoining WHO further supports this outlook.
No significant business impact is expected.
Guidance: Retain FY 2025 Outlook, Revenue Growth & EBITDA Margin See An Improvement